Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American States Water Company (AWR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

American States Water CompanyTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

American States Water Company vs Regeneron Pharmaceuticals Inc — how do they compare? American States Water Company trades at $84.85 (market cap $3.33B), while Regeneron Pharmaceuticals Inc trades at $655.64 (market cap $68.79B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 20.7× American States Water Company's market cap, and American States Water Company pays the higher dividend (2.37%). Which is the better fit depends on your goals.

AWRREGN
Market Cap
$3.33B$68.79B
Sector
UtilitiesHealth
52-Week High
$85.05$812.27
52-Week Low
$70.10$542.52
Enterprise Value
$4.24B$62.74B
Dividend Yield
2.37%0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American States Water Company

American States Water (AWR) trades at $85.05, up 0.64% today, with a bullish technical signal from moving averages and strong profitability metrics including a 19.66% net income margin. Recent news highlights its inclusion in TIME's America's Best Companies 2026 list and a completed $200 million ATM equity offering. The stock shows consistent dividend performance with a 71-year growth streak, though recent quarters saw mixed earnings results versus expectations.

Outlook remains stable with revenue growth to $679 million in 2026 and solid cash flow, but risks include regulatory pressures and interest rate sensitivity. Analysts are cautious with only 20% buy ratings. The stock offers defensive appeal but faces execution risks in a high-valuation environment.

Regeneron Pharmaceuticals Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American States Water Company

American States Water provides water and electric services to over one million people in the U.S. It also manages water and wastewater systems for various military bases under long-term privatization contracts.

Read more on AWR

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN